| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A. Denver Russell
|
Denyer, Stephen
|
|
2005
|
|
10 |
p. 1441-1442
2 p.
|
artikel
|
| 2 |
Advancements in adenoviral based virotherapy for ovarian cancer
|
Matthews, Kellie S.
|
|
2009
|
|
10 |
p. 836-841
6 p.
|
artikel
|
| 3 |
Amino acids as promoieties in prodrug design and development
|
Vig, Balvinder S.
|
|
2013
|
|
10 |
p. 1370-1385
16 p.
|
artikel
|
| 4 |
Antibiotic resistance—the problem intensifies
|
Levy, Stuart B.
|
|
2005
|
|
10 |
p. 1446-1450
5 p.
|
artikel
|
| 5 |
Antiepileptic drug delivery
|
Baum, Larry
|
|
2012
|
|
10 |
p. 885-886
2 p.
|
artikel
|
| 6 |
Antimicrobial drug delivery in food animals and microbial food safety concerns: an overview of in vitro and in vivo factors potentially affecting the animal gut microflora
|
Yan, S.Steve
|
|
2004
|
|
10 |
p. 1497-1521
25 p.
|
artikel
|
| 7 |
Bacterial resistance to antibiotics: Active efflux and reduced uptake
|
Kumar, Ayush
|
|
2005
|
|
10 |
p. 1486-1513
28 p.
|
artikel
|
| 8 |
Bacterial resistance to antibiotics: Enzymatic degradation and modification
|
Wright, Gerard D.
|
|
2005
|
|
10 |
p. 1451-1470
20 p.
|
artikel
|
| 9 |
Bacterial resistance to antibiotics: Modified target sites
|
Lambert, Peter A.
|
|
2005
|
|
10 |
p. 1471-1485
15 p.
|
artikel
|
| 10 |
Biodegradable polymers and their potential use in parenteral veterinary drug delivery systems
|
Winzenburg, Gesine
|
|
2004
|
|
10 |
p. 1453-1466
14 p.
|
artikel
|
| 11 |
Biofilms and antibiotic therapy: Is there a role for combating bacterial resistance by the use of novel drug delivery systems?
|
Smith, Anthony W.
|
|
2005
|
|
10 |
p. 1539-1550
12 p.
|
artikel
|
| 12 |
Cerebral expression of drug transporters in epilepsy
|
Aronica, Eleonora
|
|
2012
|
|
10 |
p. 919-929
11 p.
|
artikel
|
| 13 |
Chemical properties of antiepileptic drugs (AEDs)
|
Bialer, Meir
|
|
2012
|
|
10 |
p. 887-895
9 p.
|
artikel
|
| 14 |
Clinical development of PEGylated recombinant staphylokinase (PEG–Sak) for bolus thrombolytic treatment of patients with acute myocardial infarction
|
Moreadith, Randall W
|
|
2003
|
|
10 |
p. 1337-1345
9 p.
|
artikel
|
| 15 |
Clinical impact and relevance of antibiotic resistance
|
French, G.L.
|
|
2005
|
|
10 |
p. 1514-1527
14 p.
|
artikel
|
| 16 |
Companion animal physiology and dosage form performance
|
Sutton, Steven C
|
|
2004
|
|
10 |
p. 1383-1398
16 p.
|
artikel
|
| 17 |
Corrigendum to “Real-time multiple-particle tracking: Applications to drug and gene delivery” [Advanced Drug Delivery Reviews 57(2005)63–78]
|
Suh, Junghae
|
|
2005
|
|
10 |
p. 1551-
1 p.
|
artikel
|
| 18 |
Curb challenges of the “Trojan Horse” approach: Smart strategies in achieving effective yet safe cell-penetrating peptide-based drug delivery
|
Huang, Yongzhuo
|
|
2013
|
|
10 |
p. 1299-1315
17 p.
|
artikel
|
| 19 |
Current challenges in clinical management of endometrial cancer
|
Montejo, Michael
|
|
2009
|
|
10 |
p. 883-889
7 p.
|
artikel
|
| 20 |
Current oral and non-oral routes of antiepileptic drug delivery
|
Anderson, Gail D.
|
|
2012
|
|
10 |
p. 911-918
8 p.
|
artikel
|
| 21 |
Current status and potential application of ISCOMs in veterinary medicine
|
Morein, Bror
|
|
2004
|
|
10 |
p. 1367-1382
16 p.
|
artikel
|
| 22 |
CYP2A6 genetic variation and potential consequences
|
Xu, Chun
|
|
2002
|
|
10 |
p. 1245-1256
12 p.
|
artikel
|
| 23 |
CYP2C9 allelic variants: ethnic distribution and functional significance
|
Xie, Hong-Guang
|
|
2002
|
|
10 |
p. 1257-1270
14 p.
|
artikel
|
| 24 |
Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases
|
Edwards III, Carl K
|
|
2003
|
|
10 |
p. 1315-1336
22 p.
|
artikel
|
| 25 |
Driving delivery vehicles with ultrasound
|
Ferrara, Katherine W.
|
|
2008
|
|
10 |
p. 1097-1102
6 p.
|
artikel
|
| 26 |
Drug delivery for in vitro fertilization: Rationale, current strategies and challenges
|
Janát-Amsbury, Margit M.
|
|
2009
|
|
10 |
p. 871-882
12 p.
|
artikel
|
| 27 |
Editorial
|
Ghandehari, Hamidreza
|
|
2013
|
|
10 |
p. 1283-
1 p.
|
artikel
|
| 28 |
Editorial Board
|
|
|
2009
|
|
10 |
p. ii-
1 p.
|
artikel
|
| 29 |
Editorial Board
|
|
|
2013
|
|
10 |
p. ii-
1 p.
|
artikel
|
| 30 |
Editorial Board
|
|
|
2003
|
|
10 |
p. ii-
1 p.
|
artikel
|
| 31 |
Editorial Board
|
|
|
2002
|
|
10 |
p. ii-
1 p.
|
artikel
|
| 32 |
Editorial Board
|
|
|
2004
|
|
10 |
p. ii-
1 p.
|
artikel
|
| 33 |
Editorial Board
|
|
|
2008
|
|
10 |
p. ii-
1 p.
|
artikel
|
| 34 |
Editorial Board
|
|
|
2005
|
|
10 |
p. ii-
1 p.
|
artikel
|
| 35 |
Editorial Board
|
|
|
2012
|
|
10 |
p. ii-
1 p.
|
artikel
|
| 36 |
Endometrial Cancer—current state of the art therapies and unmet clinical needs: The role of surgery and preoperative radiographic assessment
|
Hunn, Jessica
|
|
2009
|
|
10 |
p. 890-895
6 p.
|
artikel
|
| 37 |
Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview
|
Mignani, Serge
|
|
2013
|
|
10 |
p. 1316-1330
15 p.
|
artikel
|
| 38 |
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations
|
Hackett, Michael J.
|
|
2013
|
|
10 |
p. 1331-1339
9 p.
|
artikel
|
| 39 |
Fetal gene therapy: Opportunities and risks
|
Wagner, Anna M.
|
|
2009
|
|
10 |
p. 813-821
9 p.
|
artikel
|
| 40 |
filler CEP BW
|
|
|
2003
|
|
10 |
p. I-
1 p.
|
artikel
|
| 41 |
Fusion protein linkers: Property, design and functionality
|
Chen, Xiaoying
|
|
2013
|
|
10 |
p. 1357-1369
13 p.
|
artikel
|
| 42 |
Gene therapy of benign gynecological diseases
|
Hassan, Memy H.
|
|
2009
|
|
10 |
p. 822-835
14 p.
|
artikel
|
| 43 |
Genetic contribution to variable human CYP3A-mediated metabolism
|
Lamba, Jatinder K
|
|
2002
|
|
10 |
p. 1271-1294
24 p.
|
artikel
|
| 44 |
Guide to Authors
|
|
|
2003
|
|
10 |
p. 1347-1350
4 p.
|
artikel
|
| 45 |
Guide to Authors
|
|
|
2002
|
|
10 |
p. 1353-1355
3 p.
|
artikel
|
| 46 |
Guide to Authors
|
|
|
2004
|
|
10 |
p. 1523-1526
4 p.
|
artikel
|
| 47 |
Host factors affecting antiepileptic drug delivery—Pharmacokinetic variability
|
Johannessen Landmark, Cecilie
|
|
2012
|
|
10 |
p. 896-910
15 p.
|
artikel
|
| 48 |
Hypoxia targeting gene expression for breast cancer gene therapy
|
Lee, Minhyung
|
|
2009
|
|
10 |
p. 842-849
8 p.
|
artikel
|
| 49 |
Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers
|
Bae, Younsoo
|
|
2009
|
|
10 |
p. 768-784
17 p.
|
artikel
|
| 50 |
Intestinal drug transporters: An overview
|
Estudante, Margarida
|
|
2013
|
|
10 |
p. 1340-1356
17 p.
|
artikel
|
| 51 |
Issues and challenges in developing long-acting veterinary antibiotic formulations
|
Sun, Yichun
|
|
2004
|
|
10 |
p. 1481-1496
16 p.
|
artikel
|
| 52 |
Issues and challenges in developing ruminal drug delivery systems
|
Vandamme, Th.F
|
|
2004
|
|
10 |
p. 1415-1436
22 p.
|
artikel
|
| 53 |
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|
van der Meel, Roy
|
|
2013
|
|
10 |
p. 1284-1298
15 p.
|
artikel
|
| 54 |
Liposomes in ultrasonic drug and gene delivery
|
Huang, Shao-Ling
|
|
2008
|
|
10 |
p. 1167-1176
10 p.
|
artikel
|
| 55 |
Low-frequency sonophoresis: Current status and future prospects
|
Ogura, Makoto
|
|
2008
|
|
10 |
p. 1218-1223
6 p.
|
artikel
|
| 56 |
Mechanisms of antimicrobial resistance: opportunities for new targeted therapies
|
Poole, Keith
|
|
2005
|
|
10 |
p. 1443-1445
3 p.
|
artikel
|
| 57 |
Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development
|
Majumdar, Soumyajit
|
|
2004
|
|
10 |
p. 1437-1452
16 p.
|
artikel
|
| 58 |
Micelles and nanoparticles for ultrasonic drug and gene delivery
|
Husseini, Ghaleb A.
|
|
2008
|
|
10 |
p. 1137-1152
16 p.
|
artikel
|
| 59 |
Microbubbles in ultrasound-triggered drug and gene delivery
|
Hernot, Sophie
|
|
2008
|
|
10 |
p. 1153-1166
14 p.
|
artikel
|
| 60 |
Mirena® (Levonorgestrel intrauterine system): A successful novel drug delivery option in contraception
|
Rose, Susan
|
|
2009
|
|
10 |
p. 808-812
5 p.
|
artikel
|
| 61 |
Novel methods of antiepileptic drug delivery — Polymer-based implants
|
Halliday, Amy J.
|
|
2012
|
|
10 |
p. 953-964
12 p.
|
artikel
|
| 62 |
Novel nanomedicine-based MRI contrast agents for gynecological malignancies
|
Mody, Vicky V.
|
|
2009
|
|
10 |
p. 795-807
13 p.
|
artikel
|
| 63 |
Novel target sites in bacteria for overcoming antibiotic resistance
|
Black, Michael T.
|
|
2005
|
|
10 |
p. 1528-1538
11 p.
|
artikel
|
| 64 |
OncoGel (ReGel/paclitaxel) — Clinical applications for a novel paclitaxel delivery system
|
Elstad, Nancy L.
|
|
2009
|
|
10 |
p. 785-794
10 p.
|
artikel
|
| 65 |
Oral delivery of medications to companion animals: palatability considerations
|
Thombre, Avinash G
|
|
2004
|
|
10 |
p. 1399-1413
15 p.
|
artikel
|
| 66 |
Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant
|
Hafner, Annina M.
|
|
2013
|
|
10 |
p. 1386-1399
14 p.
|
artikel
|
| 67 |
Pegaspargase: a review of clinical studies
|
Graham, Michael L.
|
|
2003
|
|
10 |
p. 1293-1302
10 p.
|
artikel
|
| 68 |
Pegvisomant in the treatment of acromegaly
|
Parkinson, C
|
|
2003
|
|
10 |
p. 1303-1314
12 p.
|
artikel
|
| 69 |
PEGylation of growth hormone-releasing hormone (GRF) analogues
|
Esposito, P
|
|
2003
|
|
10 |
p. 1279-1291
13 p.
|
artikel
|
| 70 |
Peptide and protein pegylation II – clinical evaluation
|
|
|
2003
|
|
10 |
p. 1259-1260
2 p.
|
artikel
|
| 71 |
Pharmacogenetics: Is the right drug for the right patient sufficient?
|
Brouwer, Kim L.R
|
|
2002
|
|
10 |
p. 1243-1244
2 p.
|
artikel
|
| 72 |
Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances
|
|
|
2002
|
|
10 |
p. 1241-1242
2 p.
|
artikel
|
| 73 |
Pharmacogenomics of organic anion-transporting polypeptides (OATP)
|
Tirona, Rommel G
|
|
2002
|
|
10 |
p. 1343-1352
10 p.
|
artikel
|
| 74 |
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)–protein conjugates
|
Caliceti, Paolo
|
|
2003
|
|
10 |
p. 1261-1277
17 p.
|
artikel
|
| 75 |
Potential applications of chitosan in veterinary medicine
|
Şenel, Sevda
|
|
2004
|
|
10 |
p. 1467-1480
14 p.
|
artikel
|
| 76 |
Publisher`s Note
|
|
|
2003
|
|
10 |
p. v-
1 p.
|
artikel
|
| 77 |
Response of contrast agents to ultrasound
|
Sboros, Vassilis
|
|
2008
|
|
10 |
p. 1117-1136
20 p.
|
artikel
|
| 78 |
Role of CNS efflux drug transporters in antiepileptic drug delivery: Overcoming CNS efflux drug transport
|
Potschka, Heidrun
|
|
2012
|
|
10 |
p. 943-952
10 p.
|
artikel
|
| 79 |
Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition
|
Suzuki, Hiroshi
|
|
2002
|
|
10 |
p. 1311-1331
21 p.
|
artikel
|
| 80 |
siRNA delivery systems for cancer treatment
|
Oh, Yu-Kyoung
|
|
2009
|
|
10 |
p. 850-862
13 p.
|
artikel
|
| 81 |
Sustained release veterinary parenteral products
|
Medlicott, Natalie J
|
|
2004
|
|
10 |
p. 1345-1365
21 p.
|
artikel
|
| 82 |
The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans
|
Fromm, Martin F
|
|
2002
|
|
10 |
p. 1295-1310
16 p.
|
artikel
|
| 83 |
Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5
|
Adachi, Masashi
|
|
2002
|
|
10 |
p. 1333-1342
10 p.
|
artikel
|
| 84 |
The Role of Gene- and Drug Delivery in women's health - Unmet clinical needs and future opportunities
|
Janát-Amsbury, Margit M.
|
|
2009
|
|
10 |
p. 767-
1 p.
|
artikel
|
| 85 |
The transport of antiepileptic drugs by P-glycoprotein
|
Zhang, Chunbo
|
|
2012
|
|
10 |
p. 930-942
13 p.
|
artikel
|
| 86 |
Ultrasonic gene and drug delivery to the cardiovascular system
|
Mayer, Christian R.
|
|
2008
|
|
10 |
p. 1177-1192
16 p.
|
artikel
|
| 87 |
Ultrasound, cavitation bubbles and their interaction with cells
|
Wu, Junru
|
|
2008
|
|
10 |
p. 1103-1116
14 p.
|
artikel
|
| 88 |
Ultrasound for drug and gene delivery to the brain
|
Hynynen, Kullervo
|
|
2008
|
|
10 |
p. 1209-1217
9 p.
|
artikel
|
| 89 |
Ultrasound in drug and gene delivery
|
Pitt, William G.
|
|
2008
|
|
10 |
p. 1095-1096
2 p.
|
artikel
|
| 90 |
Ultrasound mediated delivery of drugs and genes to solid tumors
|
Frenkel, Victor
|
|
2008
|
|
10 |
p. 1193-1208
16 p.
|
artikel
|
| 91 |
Veterinary drug delivery: Part VI
|
Rathbone, Michael J
|
|
2004
|
|
10 |
p. 1339-1344
6 p.
|
artikel
|
| 92 |
Women and heart disease — Physiologic regulation of gene delivery and expression: Bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease
|
Yockman, James W.
|
|
2009
|
|
10 |
p. 863-870
8 p.
|
artikel
|
Tijdschrift beschrijving